Detalhe da pesquisa
1.
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies.
Thromb J
; 14(Suppl 1): 29, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27766055
2.
Efficacy and Safety of Anti-Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial.
JTO Clin Res Rep
; 4(4): 100478, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37020926
3.
Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.
Clin Appl Thromb Hemost
; 27: 10760296211018510, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34047195
4.
In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.
Sci Rep
; 11(1): 11663, 2021 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34083615
5.
Comprehensive Exome Analysis of Immunocompetent Metastatic Head and Neck Cancer Models Reveals Patient Relevant Landscapes.
Cancers (Basel)
; 12(10)2020 Oct 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33053752
6.
Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Thromb Haemost
; 111(2): 279-89, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24172860